Lynn Foster is the Founder and CEO of BPT Pharmaceuticals LLC (Multiple Sclerosis) and Z-Field Technologies LLC (Catalysis). He previously held technology industry positions in corporate, entrepreneurial and government settings. Lynn previously managed the State of California’s CalTIP commercialization program and served as the Emerging Technologies Director of a Top Ten Law Firm.
Lynn’s primary technical focus is Nanotechnology. He is the Editor and Co-Author of the best selling textbook, “Nanotechnology: Science, Innovation & Opportunity” (Prentice Hall, 2005). He wrote the first Trade Study on Nanotechnology and organized many of the early knowledge conferences and Trade Missions in the field.
Lynn serves as Chairman of the Caltech Entrepreneurs Forum and on the leadership committee of TechConnect, a national technology partnering conference that regularly draws 3000 attendees from University Technology Licensing Offices, Corporate Venture Capitalists and early stage companies. He previously served on the Nanotechnology and Emerging Technologies Committees of the US Chamber of Commerce and on the Advisory Board of Finaventures, a Venture Capital fund. He had 21 years of active and reserve service with the US Army including service in the first Gulf War and Bosnia.